BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee

The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was convened on December 1, 2016 at the American Society of Hematology (ASH) meeting to discuss the emerging data and technologies for minimal residual disea...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Main Authors: Holstein, Sarah A., Avet-Loiseau, Hervé, Hahn, Theresa, Ho, Christine M., Lohr, Jens G., Munshi, Nikhil C., Paiva, Bruno, Pasquini, Marcelo C., Tario, Joseph D., Usmani, Saad Z., Wallace, Paul K., Weisel, Katja, McCarthy, Philip L.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5902638/
https://ncbi.nlm.nih.gov/pubmed/29242112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.12.774
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares